Zurcher Kantonalbank (Zurich Cantonalbank) Amneal Pharmaceuticals, Inc. Transaction History
Zurcher Kantonalbank (Zurich Cantonalbank)
- $33.8 Billion
- Q1 2025
A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Amneal Pharmaceuticals, Inc. stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 57,276 shares of AMRX stock, worth $424,987. This represents 0.0% of its overall portfolio holdings.
Number of Shares
57,276
Previous 43,812
30.73%
Holding current value
$424,987
Previous $346,000
38.44%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding AMRX
# of Institutions
244Shares Held
136MCall Options Held
302KPut Options Held
103K-
Vanguard Group Inc Valley Forge, PA15.8MShares$117 Million0.0% of portfolio
-
Tpg Gp A, LLC Fort Worth, TX12.3MShares$91.5 Million3.16% of portfolio
-
Black Rock Inc. New York, NY11.3MShares$83.7 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY10.7MShares$79.7 Million2.58% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il7.49MShares$55.6 Million0.01% of portfolio
About Amneal Pharmaceuticals, Inc.
- Ticker AMRX
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 151,408,992
- Market Cap $1.12B
- Description
- Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...